Changes in prescription habits with the introduction of generic fluoxetine

Military Medicine

Volumn 173, Issue 1, 2008, Pages 100-104

  McLay, Robert ^a   Klinski, Angelica ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; GENERIC DRUG; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; DRUG COST; DRUG MARKETING; HUMAN; LINEAR REGRESSION ANALYSIS; PRESCRIPTION; PUBLIC HOSPITAL;

EID: 38149126929     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.173.1.100     Document Type: Article

References (10)

1. Nurnberg HG, Thompson PM, Hensley PL: Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors. J Clin Psychiatry 1999; 60: 574-9.
2. De Las Cuevas C, Sanz EJ, De La Fuente JA: Variations in antidepressant prescribing practice: clinical need or market influences? Pharmacoepidemiol Drug Saf 2002; 11: 515-22.
3. Druss BG, Marcus SC, Olfson M, Pincus HA: Listening to generic Prozac: winners, losers, and sideliners: the market share of generic fluoxetine that of its brand-name counterpart, Prozac, at an unprecedented rate: within two weeks of the generic's introduction. Health Aff (Millwood) 2004; 23: 210-6.
4. Hemeryck A, Belpaire FM: Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Curr Drug Metab 2002; 3: 13-37.
5. Berndt ER, Bhattacharjya A, Mishol DN, Arcelus A, Lasky T: An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts. J Ment Health Policy Econ 2002; 5: 3-19.
6. Hensley PL, Nurnberg HG: Formulary restriction of selective serotonin reuptake inhibitors for depression: potential pitfalls. Pharmacoeconomics 2001; 19: 973-82.
7. McCormick BB, Tomlinson G, Brill-Edwards P, Detsky AS: Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA 2001; 286: 1994-9.
8. Gehlbach SH, Wilkinson WE, Hammond WE, et al: Improving drug prescribing in a primary care practice. Med Care 1984; 22: 193-201.
9. Doupe M, Katz A, Kvern B, et al: Encouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial. BMC Health Serv Res 2004; 24; 4: 21.
10. Agrawal S, Saluja I, Kaczorowski J: A prospective before-and-after trial of an educational intervention about pharmaceutical marketing. Acad Med 2004; 79: 1046-50.